GlassScriptPhysician profile
Rahool S Karnik
NPI 1932183563
$14,768.61
in general payments reported to CMS, 2019-2025
46 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,589 · 2020: $1,484 · 2021: $1,430 · 2022: $2,586 · 2023: $1,796 · 2024: $2,193 · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,679.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,822.72 | 2019-2025 | Cardiomems, Mitraclip, Aveir |
| Boston Scientific Corporation | $1,578.81 | 2019-2024 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $1,118.06 | 2019-2025 | |
| Medtronic, INC. | $936.15 | 2021-2025 | Micra, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $775.96 | 2020-2025 | Lifevest |
| Amgen INC. | $701.20 | 2019-2025 | Repatha, Repatha |
| Biosense Webster, INC. | $598.33 | 2019-2020 | |
| Edwards Lifesciences Corporation | $575.77 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biotronik INC. | $575.13 | 2019-2024 | Amvia Edge |
| Kestra Medical Technology Services, INC. | $541.79 | 2022-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $498.68 | 2022-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $487.17 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $383.58 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $365.70 | 2019-2023 | Farxiga |
| Regeneron Pharmaceuticals, INC. | $253.48 | 2019 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahool Karnik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.